Literature DB >> 23098233

Effect of the poly(ethylene glycol) (PEG) density on the access and uptake of particles by antigen-presenting cells (APCs) after subcutaneous administration.

Xi Zhan1, Kenny K Tran, Hong Shen.   

Abstract

Lymphatic trafficking of particles to the secondary lymphoid organs, such as lymph nodes, and the cell types that particles access are critical factors that control the quality and quantity of immune responses. In this study, we evaluated the effect of PEGylation on the lymphatic trafficking and accumulation of particles in draining lymph nodes (dLNs) as well as the cell types that internalized particles. As a model system, 200 nm polystyrene (PS) particles were modified with different densities of poly(ethylene glycol) (PEG) and administered subcutaneously to mice. PEGylation enhanced the efficiency of particle drainage away from the injection site as well as the access of particles to dendritic cells (DCs). The accumulation of particles in dLNs was dependent on the PEG density. PEGylation also enhanced uptake by DCs while reducing internalization by B cells at the single cell level. Our results indicate that PEGylation facilitated the trafficking of particles to dLNs either through enhanced trafficking in lymphatic vessels or by enhanced internalization by migratory DCs. This study provides insight into utilizing PEGylated particles for the development of synthetic vaccines.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23098233      PMCID: PMC3849130          DOI: 10.1021/mp300190g

Source DB:  PubMed          Journal:  Mol Pharm        ISSN: 1543-8384            Impact factor:   4.939


  61 in total

Review 1.  Dendritic cell subsets and lineages, and their functions in innate and adaptive immunity.

Authors:  Y J Liu
Journal:  Cell       Date:  2001-08-10       Impact factor: 41.582

Review 2.  Interstitial flow and its effects in soft tissues.

Authors:  Melody A Swartz; Mark E Fleury
Journal:  Annu Rev Biomed Eng       Date:  2007       Impact factor: 9.590

3.  Most lymphoid organ dendritic cell types are phenotypically and functionally immature.

Authors:  Nicholas S Wilson; Dima El-Sukkari; Gabrielle T Belz; Christopher M Smith; Raymond J Steptoe; William R Heath; Ken Shortman; José A Villadangos
Journal:  Blood       Date:  2003-06-05       Impact factor: 22.113

Review 4.  Dendritic cell subsets in primary and secondary T cell responses at body surfaces.

Authors:  William R Heath; Francis R Carbone
Journal:  Nat Immunol       Date:  2009-11-16       Impact factor: 25.606

5.  Determining the conformation of thiolated poly(ethylene glycol) on Au nanoshells by surface-enhanced Raman scattering spectroscopic assay.

Authors:  Carly S Levin; Sandra Whaley Bishnoi; Nathaniel K Grady; Naomi J Halas
Journal:  Anal Chem       Date:  2006-05-15       Impact factor: 6.986

6.  Lymphatic uptake and biodistribution of liposomes after subcutaneous injection: III. Influence of surface modification with poly(ethyleneglycol).

Authors:  C Oussoren; G Storm
Journal:  Pharm Res       Date:  1997-10       Impact factor: 4.200

7.  The role of phagosomal pH on the size-dependent efficiency of cross-presentation by dendritic cells.

Authors:  Kenny K Tran; Hong Shen
Journal:  Biomaterials       Date:  2008-12-16       Impact factor: 12.479

8.  Efficient major histocompatibility complex class I presentation of exogenous antigen upon phagocytosis by macrophages.

Authors:  M Kovacsovics-Bankowski; K Clark; B Benacerraf; K L Rock
Journal:  Proc Natl Acad Sci U S A       Date:  1993-06-01       Impact factor: 11.205

9.  The microbial mimic poly IC induces durable and protective CD4+ T cell immunity together with a dendritic cell targeted vaccine.

Authors:  Christine Trumpfheller; Marina Caskey; Godwin Nchinda; Maria Paula Longhi; Olga Mizenina; Yaoxing Huang; Sarah J Schlesinger; Marco Colonna; Ralph M Steinman
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-06       Impact factor: 11.205

10.  Multiple dendritic cell populations activate CD4+ T cells after viral stimulation.

Authors:  Adele M Mount; Christopher M Smith; Fiona Kupresanin; Kristina Stoermer; William R Heath; Gabrielle T Belz
Journal:  PLoS One       Date:  2008-02-27       Impact factor: 3.240

View more
  15 in total

1.  Polymer blend particles with defined compositions for targeting antigen to both class I and II antigen presentation pathways.

Authors:  Kenny K Tran; Xi Zhan; Hong Shen
Journal:  Adv Healthc Mater       Date:  2013-10-02       Impact factor: 9.933

Review 2.  Immune Tolerance for Autoimmune Disease and Cell Transplantation.

Authors:  Xunrong Luo; Stephen D Miller; Lonnie D Shea
Journal:  Annu Rev Biomed Eng       Date:  2016-02-24       Impact factor: 9.590

3.  Rapid and Persistent Delivery of Antigen by Lymph Node Targeting PRINT Nanoparticle Vaccine Carrier To Promote Humoral Immunity.

Authors:  Sarah N Mueller; Shaomin Tian; Joseph M DeSimone
Journal:  Mol Pharm       Date:  2015-04-08       Impact factor: 4.939

4.  Reduction Sensitive PEG Hydrogels for Codelivery of Antigen and Adjuvant To Induce Potent CTLs.

Authors:  Chintan H Kapadia; Shaomin Tian; Jillian L Perry; J Christopher Luft; Joseph M DeSimone
Journal:  Mol Pharm       Date:  2016-09-22       Impact factor: 4.939

5.  Arginine dependence of acute myeloid leukemia blast proliferation: a novel therapeutic target.

Authors:  Francis Mussai; Sharon Egan; Joseph Higginbotham-Jones; Tracey Perry; Andrew Beggs; Elena Odintsova; Justin Loke; Guy Pratt; Kin Pong U; Anthony Lo; Margaret Ng; Pamela Kearns; Paul Cheng; Carmela De Santo
Journal:  Blood       Date:  2015-02-20       Impact factor: 22.113

6.  PEGylation of interferon α2 improves lymphatic exposure after subcutaneous and intravenous administration and improves antitumour efficacy against lymphatic breast cancer metastases.

Authors:  Lisa M Kaminskas; David B Ascher; Victoria M McLeod; Marco J Herold; Caroline P Le; Erica K Sloan; Christopher J H Porter
Journal:  J Control Release       Date:  2013-03-15       Impact factor: 9.776

7.  A vaccine combination of lipid nanoparticles and a cholera toxin adjuvant derivative greatly improves lung protection against influenza virus infection.

Authors:  Valentina Bernasconi; Karin Norling; Inta Gribonika; Li Ching Ong; Sabina Burazerovic; Nagma Parveen; Karin Schön; Anneli Stensson; Marta Bally; Göran Larson; Fredrik Höök; Nils Lycke
Journal:  Mucosal Immunol       Date:  2020-08-17       Impact factor: 7.313

Review 8.  PEGylation as a strategy for improving nanoparticle-based drug and gene delivery.

Authors:  Jung Soo Suk; Qingguo Xu; Namho Kim; Justin Hanes; Laura M Ensign
Journal:  Adv Drug Deliv Rev       Date:  2015-10-09       Impact factor: 15.470

9.  Nano-Immune-Engineering Approaches to Advance Cancer Immunotherapy: Lessons from Ultra-pH-Sensitive Nanoparticles.

Authors:  Suxin Li; Zachary T Bennett; Baran D Sumer; Jinming Gao
Journal:  Acc Chem Res       Date:  2020-10-16       Impact factor: 22.384

Review 10.  Revolutionizing polymer-based nanoparticle-linked vaccines for targeting respiratory viruses: A perspective.

Authors:  Yinghan Chan; Sin Wi Ng; Sachin Kumar Singh; Monica Gulati; Gaurav Gupta; Sushil Kumar Chaudhary; Goh Bey Hing; Trudi Collet; Ronan MacLoughlin; Raimar Löbenberg; Brian G Oliver; Dinesh Kumar Chellappan; Kamal Dua
Journal:  Life Sci       Date:  2021-06-24       Impact factor: 6.780

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.